3-cyclopropyl-N-methyl-1-[3-(1-methylpyrazol-4-yl)isoquinolin-8-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxamide;3-(3,3-difluorocyclobutyl)-N-methyl-1-[3-(oxan-4-yl)isoquinolin-8-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxamide;N-methyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxamide
C77H84F2N18O5S — CID 158308400
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-cyclopropyl-N-methyl-1-[3-(1-methylpyrazol-4-yl)isoquinolin-8-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxamide;3-(3,3-difluorocyclobutyl)-N-methyl-1-[3-(oxan-4-yl)isoquinolin-8-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxamide;N-methyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxamide
3-cyclopropyl-N-methyl-1-[3-(1-methylpyrazol-4-yl)isoquinolin-8-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxamide;3-(3,3-difluorocyclobutyl)-N-methyl-1-[3-(oxan-4-yl)isoquinolin-8-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxamide;N-methyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxamide (PubChem CID 158308400) has the molecular formula C77H84F2N18O5S and a molecular weight of 1411.70 g/mol. Its IUPAC name is 3-cyclopropyl-N-methyl-1-[3-(1-methylpyrazol-4-yl)isoquinolin-8-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxamide;3-(3,3-difluorocyclobutyl)-N-methyl-1-[3-(oxan-4-yl)isoquinolin-8-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxamide;N-methyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxamide.
Molecular Properties
| Compound Name | 3-cyclopropyl-N-methyl-1-[3-(1-methylpyrazol-4-yl)isoquinolin-8-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxamide;3-(3,3-difluorocyclobutyl)-N-methyl-1-[3-(oxan-4-yl)isoquinolin-8-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxamide;N-methyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxamide |
|---|---|
| PubChem CID | 158308400 |
| Molecular Formula | C77H84F2N18O5S |
| Molecular Weight | 1411.70 g/mol |
| Exact Mass | 1410.66 |
| IUPAC Name | 3-cyclopropyl-N-methyl-1-[3-(1-methylpyrazol-4-yl)isoquinolin-8-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxamide;3-(3,3-difluorocyclobutyl)-N-methyl-1-[3-(oxan-4-yl)isoquinolin-8-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxamide;N-methyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxamide |
| SMILES | CNC(=O)N1CCn2c(C3CC(F)(F)C3)nc(-c3cccc4cc(C5CCOCC5)ncc34)c2C1.CNC(=O)N1CCn2c(C3CC3)nc(-c3cccc4cc(-c5cnn(C)c5)ncc34)c2C1.CNC(=O)N1CCn2c(C3CCOCC3)nc(-c3c(C)ccc4cc(-c5cnc(C)s5)ncc34)c2C1 |
| InChI | InChI=1S/C27H30N6O2S.C26H29F2N5O2.C24H25N7O/c1-16-4-5-19-12-21(23-14-29-17(2)36-23)30-13-20(19)24(16)25-22-15-32(27(34)28-3)8-9-33(22)26(31-25)18-6-10-35-11-7-18;1-29-25(34)32-7-8-33-22(15-32)23(31-24(33)18-12-26(27,28)13-18)19-4-2-3-17-11-21(30-14-20(17)19)16-5-9-35-10-6-16;1-25-24(32)30-8-9-31-21(14-30)22(28-23(31)15-6-7-15)18-5-3-4-16-10-20(26-12-19(16)18)17-11-27-29(2)13-17/h4-5,12-14,18H,6-11,15H2,1-3H3,(H,28,34);2-4,11,14,16,18H,5-10,12-13,15H2,1H3,(H,29,34);3-5,10-13,15H,6-9,14H2,1-2H3,(H,25,32) |
| InChIKey | GNJMXVITHMWIAL-UHFFFAOYSA-N |
| XLogP | 13.08 |
| TPSA | 238.32 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 18 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 103 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1411.70 |
| LogP ≤ 5 | 13.08 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 18 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158308400 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.